{
    "clinical_study": {
        "@rank": "61963", 
        "arm_group": [
            {
                "arm_group_label": "Inoculation in upper arm deltoid", 
                "arm_group_type": "Active Comparator", 
                "description": "Inoculation of Hib vaccine of two brands in upper arm deltoid"
            }, 
            {
                "arm_group_label": "Inoculation in vastus lateralis muscle", 
                "arm_group_type": "Experimental", 
                "description": "Inoculation of Hib vaccine of two brands in vastus lateralis muscle"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this study was to evaluate the safety and immunogenicity of Haemophilus\n      influenzae type b vaccine in different injection site."
        }, 
        "brief_title": "The Safety and Immunogenicity of Haemophilus Influenzae Type b Vaccine in Different Injection Site", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "condition_browse": {
            "mesh_term": "Influenza, Human"
        }, 
        "detailed_description": {
            "textblock": "A randomized trial was conducted in 680 healthy infants with Hib vaccine of two brands. The\n      different sub-groups were selected randomly based on the plan to inoculate vaccines in the\n      upper arm deltoid or vastus lateralis muscle. The safety and immunogenicity were assessed\n      after three or two doses."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  participants were under 1 years old, and were in good healthy\n\n          -  participants were full-time pregnancy and birth weight were more than 2.5 kg\n\n        Exclusion Criteria:\n\n          -  current infectious fever or acute disease\n\n          -  a history of hypersensitivity to study vaccine components especially tetanus toxoid\n\n          -  a history of allergy, autoimmune, convulsions, seizures heredity disease\n\n          -  a history of Hib vaccination or Hib disease\n\n          -  a history of congenital deformity, developmental disorders or serious chronic\n             diseases, muscle injection contradiction, and immunosuppressive agents, hormone or\n             immunoglobulin received."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "12 Months", 
            "minimum_age": "2 Months"
        }, 
        "enrollment": {
            "#text": "680", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01761136", 
            "org_study_id": "BJCDPC-4"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Inoculation in upper arm deltoid", 
                    "Inoculation in vastus lateralis muscle"
                ], 
                "description": "Inoculation of Hib vaccine of two brands in upper arm deltoid", 
                "intervention_name": "Inoculation in upper arm deltoid", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": [
                    "Inoculation in upper arm deltoid", 
                    "Inoculation in vastus lateralis muscle"
                ], 
                "description": "Inoculation of Hib vaccine of two brands in vastus lateralis muscle", 
                "intervention_name": "Inoculation in vastus lateralis muscle", 
                "intervention_type": "Biological"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 27, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing"
                    }, 
                    "name": "Beijing Huaxin Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China"
                    }, 
                    "name": "Xiaohongmen community health service centers"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China"
                    }, 
                    "name": "Beijing Dongba Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China"
                    }, 
                    "name": "Beijing Chaoyang Women's and Children's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China"
                    }, 
                    "name": "Cuigezhuang community health service centers"
                }
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase 4 Study of Haemophilus Influenzae Type b Vaccine in Different Injection Site", 
        "overall_official": {
            "affiliation": "Beijing Chaoyang District Center for Disease Control and Prevention", 
            "last_name": "Nianmin Shi", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Incidence rate of adverse events of Haemophilus influenzae type b vaccine in different injection site", 
            "safety_issue": "Yes", 
            "time_frame": "one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01761136"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Antibody titre of Haemophilus influenzae type b vaccine in different injection site", 
            "safety_issue": "No", 
            "time_frame": "one year"
        }, 
        "source": "Beijing Center for Disease Control and Prevention", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Beijing Center for Disease Control and Prevention", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}